Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Choose an application
This is a biography of Dr Felicia Wu. Felicia was a scientist with a successful career in cancer research, but what marked the most extraordinary aspect about her life was her journey as a truly brave cancer patient and an incredibly determined cancer fighter. Originally, this book was intended to be an autobiography written and narrated by Felicia herself. She wanted to share with other cancer sufferers her 13 long years of experience fighting cancer to prepare them for the side effects and uncertainties of the treatment, and also to encourage them to brace and face their own treatment without fear. What she did not realize then was that her time was ticking away, and her life trickling off quickly. Writing her own autobiography proved to be an impossible task. Felicia succumbed to the prolonged battle and departed from this world. Her husband, Dr Cheng-Wen Wu, finished the uncompleted task of writing the book in loving memory of her. The biography of Felicia, originally published in Chinese edition, has been recommended as a reading model for students in schools and was nominated for an award in Taiwan. Felicia's story had also inspired the production of a documentary film entitled, "A Passion for Life", funded and sponsored by The American Cancer Society. This biography of Felicia in English edition, painstakingly translated by Dr Cheng-Wen Wu and his collaborating translator, Ms Annie Chen, will certainly live up to its original premise as an inspiration to touch more lives and as a source of strength to all who encounter difficulty, disappointment and hurt at any point of their lives.
Cancer --- Women medical scientists --- Patients --- Wu, Felicia Y.-H. --- Wu, Cheng-wen --- Family.
Choose an application
In an effort to streamline care for children and youth under age 21 with needs for home- and community-based services (HCBS), New York State consolidated several prior 1915(c) waivers into a single Children's Waiver and amended their Section 1115 Medicaid Redesign Team waiver. The 1115 waiver amendment allows the state to move services covered by the consolidated Children's Waiver from fee for service to Medicaid managed care (MMC) and to target eligibility to medically needy family-of-one children who meet clinical criteria and are enrolled in the consolidated Children's Waiver but do not qualify for Medicaid due to family income. Together, these waiver amendments are called the "Children's Design," which was implemented in 2019. In this interim evaluation, the authors identify facilitators of, and barriers to, implementation of the Children's Design and describe baseline trends in outcomes of interest to its future evaluation. The authors found that: (1) providers, advocates, MMC plan representatives, and government partners perceived the transition to the Children's Design as challenging and were particularly concerned about the burden of accessing care on children's families and reductions in service availability; (2) prior to the Children's Design implementation, parents of children with chronic conditions had high levels of satisfaction with their primary care providers but were less satisfied with their ability to access special equipment and therapies and with coordination efforts among multiple providers; and (3) at baseline, the levels of quality indicators for children did not change significantly, with the exception of some primary care indicators for young children, which improved.
Choose an application
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research, and the impact of limited knowledge about women's health relative to men's is far-reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health. As part of an initiative of the Women's Health Access Matters (WHAM) nonprofit foundation, RAND Corporation researchers examined the impact of increasing funding for women's health, beginning with a focus on Alzheimer's disease and Alzheimer's disease–related dementias (AD/ADRD), which result in substantial illness burden, health care costs, caregiving burden, and mortality. In this report, the authors present the results of microsimulation models used to explore the potential for enhanced investment in women's health research, in terms of the economic well-being of women and for the U.S. population.
Choose an application
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research, and the impact of limited knowledge about women's health relative to men's is far-reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health. As part of an initiative of the Women's Health Access Matters (WHAM) nonprofit foundation, RAND Corporation researchers examined the impact of increasing funding for women's health research on coronary artery disease (CAD). CAD was chosen partly because physiological differences between men and women affect factors that relate to the development and progression of cardiovascular disease. In this report, the authors present the results of microsimulation models used to explore the potential for enhanced investment in women's health research, in terms of the economic well-being of women and for the U.S. population.
Choose an application
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research, and the impact of limited knowledge about women's health relative to men's is far-reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health. As part of an initiative of the Women's Health Access Matters (WHAM) nonprofit foundation, RAND Corporation researchers examined the impact of increasing funding for women's health research on rheumatoid arthritis (RA). RA was chosen partly because of its higher prevalence in women than men, with some symptom profiles differing by sex. In this report, the authors present the results of microsimulation models used to explore the potential for enhanced investment in women's health research, in terms of the economic well-being of women and for the U.S. population.
Choose an application
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research, and the impact of limited knowledge about women's health relative to men's is far-reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health. As part of an initiative of the Women's Health Access Matters (WHAM) nonprofit foundation, RAND Corporation researchers examined the impact of increasing funding for women's health research, with a focus on the following three disease areas: brain health, immune and autoimmune disease, and cardiovascular disease. Using microsimulation analyses, the research team studied the societal cost impact of increasing research funding in three diseases that present a large disease burden for women: Alzheimer's disease and Alzheimer's disease–related dementias (AD/ADRD), coronary artery disease (CAD), and rheumatoid arthritis (RA). The results establish the potential for investment in women's health research to realize gains beyond additional general research investment and point the way to a concrete, actionable research and funding agenda.
Choose an application
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research, and the impact of limited knowledge about women's health relative to men's is far-reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health. As part of an initiative of the Women's Health Access Matters (WHAM) nonprofit foundation, RAND Corporation researchers examined the impact of increasing funding for women's health research on lung cancer. Women are disproportionately represented among nonsmokers with lung cancer. Nonsmoking men represent just 2 percent to 6 percent of total lung cancer cases among men, but nonsmoking women represent approximately 20 percent of cases among women. In this report, the authors present the results of microsimulation models used to explore the potential for enhanced investment in women's health research, in terms of the economic well-being of women and for the U.S. population.
Listing 1 - 8 of 8 |
Sort by
|